STERIS plc Asset Resilience Ratio

Latest as of December 2025: 4.00%

STERIS plc asset resilience ratio. STERIS plc (STE) has an Asset Resilience Ratio of 4.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See STE defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$423.70 Million
Cash + Short-term Investments

Total Assets

$10.59 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of STERIS plc (2016–2025)

Asset resilience ratio of STERIS plc from 2016 to 2025. This chart shows how STERIS plc's Asset Resilience Ratio has changed over time. Read debt load of STERIS plc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down STERIS plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see STERIS plc total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $423.70 Million 4.0%
Short-term Investments $0.00 0%
Total Liquid Assets $423.70 Million 4.00%

Asset Resilience Insights

  • Limited Liquidity: STERIS plc maintains only 4.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

STERIS plc Industry Peers by Asset Resilience Ratio

Compare STERIS plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
TAIDOC TECHNOLOGY CORP
TW:4736
Medical Devices 23.03%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%

STERIS plc Asset Resilience Ratio by Year (2016–2025)

STERIS plc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for STERIS plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 1.69% $171.70 Million $10.15 Billion -0.18pp
2024-03-31 1.87% $207.02 Million $11.06 Billion -0.05pp
2023-03-31 1.93% $208.36 Million $10.82 Billion -1.12pp
2022-03-31 3.05% $348.32 Million $11.42 Billion -0.31pp
2021-03-31 3.35% $220.53 Million $6.57 Billion -2.54pp
2020-03-31 5.89% $319.58 Million $5.43 Billion +1.54pp
2019-03-31 4.35% $220.63 Million $5.07 Billion +0.47pp
2018-03-31 3.88% $201.53 Million $5.20 Billion -1.87pp
2017-03-31 5.75% $282.92 Million $4.92 Billion --
2016-03-31 0.00% $0.00 $5.35 Billion --
pp = percentage points

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$24.74 Billion
Market Cap Rank
#1230 Global
#517 in USA
Share Price
$252.30
Change (1 day)
-0.72%
52-Week Range
$199.40 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more